During and after a detox, it becomes much easier to refrain from junk food and processed foods as the cravings cease, and
early markers of disease return to normal.
«Our study shows that lipofuscin in the retina and in blood cells could serve as
an early marker of disease,» said Green, medical director of the UCSF Multiple Sclerosis Center and director of the UCSF Neurodiagnostics Center.
«We already knew that the buildup of fibrin appears early in the development of MS — both in animal models and in human patients, so we wondered whether thrombin activity could in turn serve as
an early marker of disease.»
Not exact matches
The
marker of antigens produced by pancreatic cancer has a low positive predictive value for identifying
early stage
disease.
Compared to eating
earlier in the day, prolonged delayed eating can increase weight, insulin and cholesterol levels, and negatively affect fat metabolism, and hormonal
markers implicated in heart
disease, diabetes and other health problems, according to results from researchers at the Perelman School
of Medicine at the University
of Pennsylvania.
It is unknown whether delirium can be treated to improve prognosis in critically ill patients, or whether it is a
marker of organ dysfunction or systemic
disease and an
early sign that complications are likely.
Although tau imaging is still in its
earliest stages, Ryan hopes that such imaging will accelerate drug development and that finding a blood - based biomarker for Alzheimer's to reveal risk (much like cholesterol serves as a
marker for cardiovascular risk) will change the field dramatically in terms
of how doctors can diagnose the
disease.
«This opens a new door in identifying biological
markers for dementia since we might consider using the brain's processing
of speech sounds as a new way to detect the
disease earlier,» says Dr. Claude Alain, the study's senior author and senior scientist at Baycrest's Rotman Research Institute (RRI) and professor at the University
of Toronto's psychology department.
As a result, the emphasis in
early development is on understanding the molecular underpinnings
of disease and developing
markers for therapeutic effects.
«Our findings show that a specific genetic
marker (known as allele * 2
of the HS1, 2 A enhancer region) influences not just
disease activity in RA patients, but also response to therapy in the
early stages
of their
disease,» said lead investigator Dr Gabriele Di Sante
of the Institute
of Rheumatology and Related Sciences, Catholic University
of the Sacred Heart, Rome, Italy.
A specific genetic
marker influences response to therapy in the
early stages
of RA; a link thought to be due to the gene activating a cell - signalling protein involved in the inflammatory
disease process.
A detailed understanding
of how TSPO binds to such
markers opens up novel paths for diagnostic imaging and could constitute an important step along the way to
early detection
of such
diseases and inflammations.
In this regard, intense research efforts are being channelled into finding new biological
markers that can provide information about the different stages
of the
disease and allow its
early detection, and thus facilitate its management.
«We believe that HO - 1 is a very
early marker of metabolic
disease,» says Esterbauer, whose team reports its findings today in Cell.
Researchers at the Ludwig - Maximilians - University, the German Center for Neurodegenerative Diseases (DZNE), and the Institute for Stroke and Dementia Research (ISD) in Munich, Germany, have identified a brain inflammation
marker in patients at
early asymptomatic stages
of Alzheimer's
disease.
The first big advance occurred in the
early 1990s, when epidemiological studies revealed that 90 to 95 percent
of individuals with the disorder carry a genetic
marker associated with autoimmune
disease — self - inflicted damage that occurs when the body mistakes its own tissues for a foreign invader and attacks them.
Some
markers may represent
early fingerprints
of disease.
The research team was particularly interested in children who had a headache — a strong
marker of the
early disseminated form
of the
disease — or pain and swelling
of the knee, a strong
marker of the late form
of the
disease.
This means that samples can be taken before the clinical debut
of a
disease, to identify
markers of value for
early diagnosis, improving the scope for curative treatment,» says Ulf Landegren, Professor
of Molecular Medicine at Uppsala University and member
of SciLifeLab Faculty.
Although there is currently no technology that allows
early diagnosis
of the
disease, a number
of putative
markers have been identified: their detection after diagnosis would be a useful tool to monitor the evolution
of the tumor during treatment, providing valuable prognostic information on response to a given therapy.
Abstract: Background: The Loewenstein - Acevedo Scale for Semantic Interference and Learning (LASSI - L) is a novel cognitive test that measures recovery from proactive semantic interference, which may be an
early cognitive
marker of Alzheimer's
disease (AD).
REVEAL IV is the first translational genetics study to focus upon the situation where mild
early symptoms
of a
disease (phenotype) and known genetic risk
marker (genotype) information can be used together to produce more imminent risk projections.
«Protein
markers are an exciting tool for diagnosis and
early detection
of diseases, but protein levels may vary due to many different factors.
Background: The Loewenstein - Acevedo Scale for Semantic Interference and Learning (LASSI - L) is a novel cognitive test that measures recovery from proactive semantic interference, which may be an
early cognitive
marker of Alzheimer's
disease (AD).
Gladstone and UCSF scientists show that lipofuscin in the retina and in blood cells could serve as an
early marker of certain neurodegenerative
diseases.
It's potential as a biomarker
of disease and an
early objective
marker of treatment response is genuine but still to be realized.Resting - state functional magnetic resonance imaging has made some strides in the clinical realm but significant advances are required before it can be used in a meaningful way at the single - patient level.
Non-overweight individuals in their late 60s, 70s, and
early 80s who have no outward symptoms
of Alzheimer's are more likely than their heavier peers to have biological
markers (or biomarkers)
of the
disease, the study found.
Much more impressive evidence also was published to show that the
early stages
of heart
disease, atherosclerosis, and its predictive serum cholesterol
marker, were increased much more by dietary protein than by dietary fat, especially the protein in animal - based foods.»
While I completely agree with delaying grains as long as possible because the digestion is immature
early on, research actually shows that people who carry the genetic
markers for celiac (not all carriers will actually develop celiac - there appear to be environmental conditions that contribute to its development) are least likely to develop the
disease if gluten is introduced around 6 months
of age in small quantities.
A 38 - year - old male with metabolic syndrome who had the APOE4 gene, considered a
marker for developing Alzheimer's, who was already experiencing
early stage memory problems and had a family history
of Alzheimer's
Disease (AD), was placed on a ketogenic diet combined with high - intensity interval training (HIIT) for 10 weeks.
Thermography, with its non-radiation, non-contact and low - cost basis has been clearly demonstrated to be a valuable and safe
early risk
marker of breast pathology, and an excellent case management tool for the ongoing monitoring and treatment
of breast
disease when used under carefully controlled clinical protocols.
Foundational research on homocysteine as a
marker for inflammation and
early development
of heart
disease.
Interventions targeting modifiable risk factors (eg, smoking, inactivity, and poor diet) in adult life have only limited efficacy in preventing age - related
disease.3, 4 Because
of the increasing recognition that preventable risk exposures in
early life may contribute to pathophysiological processes leading to age - related
disease, 5,6 the science
of aging has turned to a life - course perspective.7, 8 Capitalizing on this perspective, this study tested the contribution
of adverse psychosocial experiences in childhood to 3 adult conditions that are known to predict age - related
diseases: depression, inflammation, and the clustering
of metabolic risk
markers, hereinafter referred to as age - related -
disease risks.